AFG
GSK icon

Albion Financial Group’s GSK GSK Stock Holding History

Albion Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22
Closed -$1K – 644
2021
Q3 		$1K Hold
22
– – ﹤0.01% 488
2021
Q2 		$1K Buy
+22
New +$1.06K ﹤0.01% 483
2020
Q4 		$1K Buy
+22
New +$1.01K ﹤0.01% 449
2017
Q1 		– Sell
-51,695
Closed -$2.49M – 196
2016
Q4 		$2.49M Sell
51,695
-23,740
-31% -$1.17M 0.41% 46
2016
Q3 		$4.07M Buy
75,435
+6,984
+10% +$383K 0.7% 37
2016
Q2 		$3.71M Buy
68,451
+4,718
+7% +$249K 0.67% 29
2016
Q1 		$3.23M Buy
63,733
+11,038
+21% +$550K 0.55% 33
2015
Q4 		$2.66M Sell
52,695
-24,077
-31% -$1.23M 0.46% 37
2015
Q3 		$3.69M Buy
76,772
+4,088
+6% +$213K 0.67% 25
2015
Q2 		$3.78M Buy
72,684
+1,730
+2% +$97.4K 0.63% 30
2015
Q1 		$4.09M Buy
70,954
+12,529
+21% +$718K 0.7% 28
2014
Q4 		$3.12M Sell
58,425
-3,279
-5% -$183K 0.54% 32
2014
Q3 		$3.55M Buy
61,704
+3,340
+6% +$205K 0.63% 30
2014
Q2 		$3.9M Sell
58,364
-87,470
-60% -$5.92M 0.68% 33
2014
Q1 		$9.74M Buy
145,834
+3,733
+3% +$252K 1.8% 15
2013
Q4 		$9.48M Buy
142,101
+743
+0.5% +$48.2K 1.78% 15
2013
Q3 		$8.87M Buy
141,358
+5,331
+4% +$343K 1.89% 11
2013
Q2 		$8.5M Buy
+136,027
New +$8.63M 1.89% 16

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Albion Financial Group's GSK Position: Q4 2021 in Review

Albion Financial Group sold out of GSK (GSK) in Q4 2021, closing a stake of 22 shares — an estimated $1K sold.

Albion Financial Group first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $9.74M in Q1 2014. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Albion Financial Group reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Albion Financial Group sold 22 GSK shares in Q4 2021, an estimated $1K.
  • Albion Financial Group first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • Albion Financial Group's GSK position peaked at $9.74M in Q1 2014.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Albion Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.